Target type: biologicalprocess
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a TNF agonist stimulus. [GOC:dph]
Tumor necrosis factor (TNF) is a pro-inflammatory cytokine that plays a crucial role in the immune response. TNF agonists are molecules that bind to and activate TNF receptors, triggering a cascade of signaling events that ultimately lead to a variety of cellular responses. The biological process of response to TNF agonist involves a complex interplay of different signaling pathways and cellular mechanisms.
1. **Binding and Receptor Activation:**
TNF agonists bind to TNF receptors, which are transmembrane proteins expressed on various cell types. This binding initiates the activation of the receptors, triggering a conformational change that exposes intracellular signaling domains.
2. **Activation of Downstream Signaling Pathways:**
The activated TNF receptors recruit and activate intracellular signaling molecules, including adaptor proteins and kinases. These signaling molecules assemble into signaling complexes, which relay the signal downstream.
3. **Nuclear Factor-κB (NF-κB) Activation:**
One of the key signaling pathways activated by TNF agonists is the NF-κB pathway. This pathway plays a crucial role in inflammation, cell survival, and immune response. Activation of NF-κB involves the phosphorylation and degradation of the IκB protein, which normally inhibits NF-κB activity. Once IκB is degraded, NF-κB translocates to the nucleus, where it regulates the expression of genes involved in inflammation, cell survival, and immune response.
4. **Activation of MAPK Pathways:**
TNF agonists also activate mitogen-activated protein kinase (MAPK) pathways, including the JNK, p38, and ERK pathways. These pathways regulate a wide range of cellular processes, including cell proliferation, differentiation, and apoptosis.
5. **Cellular Responses:**
The activation of these signaling pathways leads to a variety of cellular responses, including:
* **Inflammation:** TNF agonists induce the production of pro-inflammatory cytokines, such as IL-1, IL-6, and TNFα itself. These cytokines promote inflammation and contribute to the immune response.
* **Cell Survival:** TNF agonists can promote cell survival by activating anti-apoptotic pathways.
* **Cell Death:** In some cases, TNF agonists can induce cell death, particularly in cancer cells.
* **Immune Modulation:** TNF agonists can modulate the immune response by regulating the activation, differentiation, and function of immune cells.
6. **Regulation of Response:**
The response to TNF agonists is tightly regulated to prevent excessive inflammation and damage. Negative feedback mechanisms are in place to dampen the signaling pathways and limit the duration of the response.
In summary, the biological process of response to TNF agonist is a complex and highly regulated process that involves a series of signaling events, leading to a variety of cellular responses. These responses play a crucial role in inflammation, immune response, and other cellular processes.'
"
Protein | Definition | Taxonomy |
---|---|---|
40S ribosomal protein S3 | A eukaryotic-type small ribosomal subunit protein uS3 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P23396] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
gentamicin sulfate | |||
PF-06446846 | PF-06446846 : A triazolopyridine that is 3H-[1,2,3]triazolo[4,5-b]pyridine substituted by a 4-{(3-chloropyridin-2-yl)[(3R)-piperidin-3-yl]carbamoyl}phenyl group at position 3. It is a potent inhibitor of PCSK9. PF-06446846: inhibits translation of PCSK9 ;structure in first source | benzamides; monochloropyridine; piperidines; tertiary carboxamide; triazolopyridine | antilipemic drug; EC 3.4.21.61 (kexin) inhibitor |